Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21388309 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Olmesartan Medoxomil in Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2;   Cardiovascular Disease;   Kidney Disease
Interventions: Drug: Olmesartan medoxomil;   Drug: Placebo Tablets

Indicates status has not been verified in more than two years